A. Patterson

BIOSIGN/spl trade/ : multi-parameter monitoring for early warning of patient deterioration

L. Tarassenko, A. Hann, A. Patterson, 2005 .

BIOSIGN™ : multi-parameter monitoring for early warning of patient deterioration

Lionel Tarassenko, E. Braithwaite, L. Tarassenko, 2005 .

Propofol 2% in critically ill patients: effect on lipids.

A. Patterson, J. Colvin, G. McLeod, 1997, Critical care medicine.

Preservation of Skin Vasoconstrictor Responses in Chronic Atherosclerotic Peripheral Vascular Disease

A. Patterson, A. V. Van rij, H. Nukada, 1998, Angiology.

OVERDOSE OF INTRAVENOUS FAT EMULSION IN A PRETERM INFANT : CASE REPORT

A. Patterson, K. Fairchild, K. Gumpper, 1999 .

Use of 2 % propofol to produce diurnal sedation in critically ill patients

A. Patterson, J. Colvin, G. McLeod, 1997, Intensive Care Medicine.